Intrexon | XON - 资产





资产 更改 日
Agenus USD 186.46M 40.34M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 92.5B 1.92B 2026-03
Anika Therapeutics USD 179.39M 10.88M 2026-03
Arrowhead Research USD 2.27B 664.08M 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Heron Therapeutics USD 246.22M 9.66M 2026-03
Incyte USD 7.34B 381.14M 2026-03
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Ligand Pharmaceuticals USD 1.53B 28.53M 2026-03
MacroGenics USD 217.87M 38.97M 2026-03
MannKind USD 744.4M 47.78M 2026-03
Merck USD 128.68B 8.18B 2026-03
Novartis USD 118.53B 7.58B 2026-03
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Veracyte USD 1.44B 30.38M 2026-03
Xencor USD 736.85M 138.65M 2026-03